PAVM - PAVmed Inc.
NASDAQ
->
Healthcare
->
Medical Devices
New York,
United States
Type: Equity
PAVM price evolution
PAVM
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.77 | $25.5 | $25.54 | $19.64 |
| Short term investments | ||||
| Net receivables | $0.02 | $0.22 | $0.07 | $0.06 |
| Inventory | $0.01 | $0.69 | $0.41 | $0.28 |
| Total current assets | $2.13 | $30.21 | $29.57 | $24.5 |
| Long term investments | ||||
| Property, plant & equipment | $2.83 | $7.1 | $5.48 | $6.05 |
| Goodwill & intangible assets | $0.95 | $1.05 | $1.42 | |
| Total noncurrent assets | $9.21 | $7.68 | $8.62 | |
| Total investments | ||||
| Total assets | $30.55 | $39.41 | $37.25 | $33.12 |
| Current liabilities | ||||
| Accounts payable | $0.47 | $1.23 | $1.49 | $1.79 |
| Deferred revenue | ||||
| Short long term debt | $45.37 | $46.87 | $45.77 | |
| Total current liabilities | $37.56 | $53.39 | $55.02 | $54.18 |
| Long term debt | $4.67 | $2.81 | $2.96 | |
| Total noncurrent liabilities | $4.67 | $2.81 | $2.96 | |
| Total debt | $50.03 | $49.69 | $48.73 | |
| Total liabilities | $35.42 | $58.05 | $57.83 | $57.14 |
| Shareholders' equity | ||||
| Retained earnings | -$256.31 | -$320.63 | -$309.72 | -$294.43 |
| Other shareholder equity | ||||
| Total shareholder equity | -$73.94 | -$68.78 | -$53.83 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $19.64 | $39.74 | $77.26 | $17.26 |
| Short term investments | ||||
| Net receivables | $0.06 | $0.02 | $0.2 | |
| Inventory | $0.28 | |||
| Total current assets | $24.5 | $43.93 | $82.64 | $18.94 |
| Long term investments | ||||
| Property, plant & equipment | $6.05 | $5.49 | $1.58 | |
| Goodwill & intangible assets | $1.42 | $3.44 | $2.03 | |
| Total noncurrent assets | $8.62 | $10.05 | $4.34 | $0.84 |
| Total investments | ||||
| Total assets | $33.12 | $53.98 | $86.98 | $19.78 |
| Current liabilities | ||||
| Accounts payable | $1.79 | $2.7 | $3.3 | $2.97 |
| Deferred revenue | ||||
| Short long term debt | $45.77 | $34.79 | $14.96 | |
| Total current liabilities | $54.18 | $41.2 | $7.56 | $20.25 |
| Long term debt | $2.96 | $1.85 | ||
| Total noncurrent liabilities | $2.96 | $1.85 | ||
| Total debt | $48.73 | $36.64 | $14.96 | |
| Total liabilities | $57.14 | $63.66 | $7.56 | $20.25 |
| Shareholders' equity | ||||
| Retained earnings | -$294.43 | -$228.17 | -$138.91 | -$88.28 |
| Other shareholder equity | $0.17 | |||
| Total shareholder equity | -$53.83 | -$9.68 | $61.67 | $1.9 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1 | $0.98 | $1.01 | $1.05 |
| Cost of revenue | $1.67 | $1.74 | $1.61 | |
| Gross Profit | -$0.39 | -$0.69 | -$0.73 | -$0.56 |
| Operating activities | ||||
| Research & development | $1.64 | $1.94 | $3.6 | |
| Selling, general & administrative | $11.25 | $10.99 | $11.72 | |
| Total operating expenses | $11.19 | $13 | $13.3 | $15.82 |
| Operating income | -$13.68 | -$14.04 | -$16.38 | |
| Income from continuing operations | ||||
| EBIT | -$10.82 | -$15.2 | -$14.02 | |
| Income tax expense | ||||
| Interest expense | $0.47 | $0.01 | $0.02 | $0.02 |
| Net income | ||||
| Net income | $64.32 | -$10.83 | -$15.21 | -$14.04 |
| Income (for common shares) | -$10.91 | -$22.79 | -$15.9 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.45 | $0.38 | $0.5 | |
| Cost of revenue | $6.42 | $3.61 | $0.58 | |
| Gross Profit | -$3.97 | -$3.24 | -$0.09 | |
| Operating activities | ||||
| Research & development | $14.28 | $25.55 | $19.85 | $10.96 |
| Selling, general & administrative | $48.53 | $60.36 | $34.46 | $12.39 |
| Total operating expenses | $64.83 | $87.69 | $54.31 | $23.35 |
| Operating income | -$68.8 | -$90.93 | -$54.39 | -$23.35 |
| Income from continuing operations | ||||
| EBIT | -$63.59 | -$87.71 | -$50.35 | -$34.22 |
| Income tax expense | ||||
| Interest expense | $0.59 | $1.27 | $0.05 | |
| Net income | ||||
| Net income | -$64.17 | -$88.98 | -$50.35 | -$34.28 |
| Income (for common shares) | -$66.27 | -$89.26 | -$50.63 | -$34.56 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$10.83 | -$15.21 | -$14.04 | |
| Operating activities | ||||
| Depreciation | $0.31 | $0.59 | $0.73 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.9 | $1.88 | $1.97 | |
| Total cash flows from operations | -$11.66 | -$13.11 | -$11.87 | |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0.04 | -$0.18 | |
| Investments | ||||
| Total cash flows from investing | -$16.18 | -$0 | -$0.04 | -$0.18 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.2 | $0.85 | $0.37 | |
| Net borrowings | -$0.21 | -$0.32 | -$0.08 | |
| Total cash flows from financing | $30.95 | $11.62 | $19.05 | $5.29 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$18.87 | -$0.04 | $5.9 | -$6.77 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$64.17 | -$88.98 | -$50.35 | -$34.28 |
| Operating activities | ||||
| Depreciation | $3.24 | $2.55 | $0.23 | $0.02 |
| Business acquisitions & disposals | -$3.2 | -$2.25 | ||
| Stock-based compensation | $11.14 | $19.53 | $15.01 | $2.04 |
| Total cash flows from operations | -$52.04 | -$70.98 | -$40.59 | -$21.91 |
| Investing activities | ||||
| Capital expenditures | $0.76 | -$1.54 | -$1.47 | -$0.06 |
| Investments | ||||
| Total cash flows from investing | $0.76 | -$4.74 | -$3.72 | -$0.06 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.79 | $0.77 | $49.79 | $16.39 |
| Net borrowings | $9.92 | $35.23 | -$14.97 | $16.7 |
| Total cash flows from financing | $31.17 | $38.21 | $104.31 | $33.01 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$20.11 | -$37.51 | $60 | $11.04 |
News
Fundamentals
| Market cap | $7.25M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 10.66M |
| Revenue | $4.03M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $24.24M |
| Revenue Q/Q | 25.92% |
| Revenue Y/Y | 166.27% |
| P/E ratio | 0.30 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.80 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.07 |
| EPS | $2.27 |
|---|---|
| ROA | 69.09% |
| ROE | N/A |
| Debt/Equity | -1.06 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.06 |
| Quick ratio | 0.06 |